• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量制备视网膜类器官。

Toward Retinal Organoids in High-Throughput.

机构信息

Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.

Department of Ophthalmology, University of Basel, Basel, Switzerland.

出版信息

Cold Spring Harb Perspect Med. 2024 Mar 1;14(3):a041275. doi: 10.1101/cshperspect.a041275.

DOI:10.1101/cshperspect.a041275
PMID:37217280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10910359/
Abstract

Human retinal organoids recapitulate the cellular diversity, arrangement, gene expression, and functional aspects of the human retina. Protocols to generate human retinal organoids from pluripotent stem cells are typically labor intensive, include many manual handling steps, and the organoids need to be maintained for several months until they mature. To generate large numbers of human retinal organoids for therapy development and screening purposes, scaling up retinal organoid production, maintenance, and analysis is of utmost importance. In this review, we discuss strategies to increase the number of high-quality retinal organoids while reducing manual handling steps. We further review different approaches to analyze thousands of retinal organoids with currently available technologies and point to challenges that still await to be overcome both in culture and analysis of retinal organoids.

摘要

人视网膜类器官再现了人类视网膜的细胞多样性、排列、基因表达和功能方面。从多能干细胞生成人视网膜类器官的方案通常劳动强度大,包括许多手动操作步骤,并且需要维持类器官几个月直到它们成熟。为了生成大量的人视网膜类器官用于治疗开发和筛选目的,扩大视网膜类器官的生产、维持和分析至关重要。在这篇综述中,我们讨论了在减少手动操作步骤的同时增加高质量视网膜类器官数量的策略。我们还进一步综述了目前可用技术分析数千个人视网膜类器官的不同方法,并指出了在视网膜类器官培养和分析中仍有待克服的挑战。

相似文献

1
Toward Retinal Organoids in High-Throughput.高通量制备视网膜类器官。
Cold Spring Harb Perspect Med. 2024 Mar 1;14(3):a041275. doi: 10.1101/cshperspect.a041275.
2
Differentiation of retinal organoids from human pluripotent stem cells.人多能干细胞来源的视网膜类器官的分化。
Methods Cell Biol. 2020;159:279-302. doi: 10.1016/bs.mcb.2020.02.005. Epub 2020 Mar 11.
3
Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects.利血平通过解决蛋白稳态失衡和纤毛发生缺陷来维持视网膜纤毛病变中的感光细胞存活。
Elife. 2023 Mar 28;12:e83205. doi: 10.7554/eLife.83205.
4
Human Organoids for the Study of Retinal Development and Disease.人类类器官在视网膜发育和疾病研究中的应用。
Annu Rev Vis Sci. 2020 Sep 15;6:91-114. doi: 10.1146/annurev-vision-121219-081855.
5
Retinal organoid light responsivity: current status and future opportunities.视网膜类器官的光反应性:现状与未来机遇。
Transl Res. 2022 Dec;250:98-111. doi: 10.1016/j.trsl.2022.06.001. Epub 2022 Jun 9.
6
Comparison of Developmental Dynamics in Human Fetal Retina and Human Pluripotent Stem Cell-Derived Retinal Tissue.人类胎儿视网膜与人类多能干细胞衍生视网膜组织的发育动力学比较。
Stem Cells Dev. 2021 Apr;30(8):399-417. doi: 10.1089/scd.2020.0085.
7
Extracellular matrix component expression in human pluripotent stem cell-derived retinal organoids recapitulates retinogenesis in vivo and reveals an important role for IMPG1 and CD44 in the development of photoreceptors and interphotoreceptor matrix.人多能干细胞源性视网膜类器官中细胞外基质成分的表达再现了体内视网膜发生过程,并揭示了 IMPG1 和 CD44 在光感受器和光感受器间基质发育中的重要作用。
Acta Biomater. 2018 Jul 1;74:207-221. doi: 10.1016/j.actbio.2018.05.023. Epub 2018 May 17.
8
New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids.用于视网膜疾病的新药发现范式:以视网膜类器官为重点。
J Ocul Pharmacol Ther. 2020 Jan/Feb;36(1):18-24. doi: 10.1089/jop.2018.0140. Epub 2019 May 6.
9
Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapies.多能干细胞衍生的视网膜类器官用于疾病建模和治疗方法的开发。
Stem Cells. 2020 Oct 1;38(10):1206-1215. doi: 10.1002/stem.3239. Epub 2020 Jun 7.
10
Human-Induced Pluripotent Stem Cells Generate Light Responsive Retinal Organoids with Variable and Nutrient-Dependent Efficiency.人诱导多能干细胞产生具有可变和营养依赖性效率的光响应视网膜类器官。
Stem Cells. 2018 Oct;36(10):1535-1551. doi: 10.1002/stem.2883. Epub 2018 Aug 13.

引用本文的文献

1
Damaging effect of ischemia on the development of retinal organoids derived from human embryonic stem cells.缺血对源自人类胚胎干细胞的视网膜类器官发育的损害作用。
Int J Ophthalmol. 2025 Aug 18;18(8):1433-1449. doi: 10.18240/ijo.2025.08.03. eCollection 2025.
2
PEGDA-based HistoBrick for increasing throughput of cryosectioning and immunohistochemistry in organoid and small tissue studies.基于聚乙二醇二丙烯酸酯的组织砖,用于提高类器官和小组织研究中冷冻切片和免疫组织化学的通量。
Sci Rep. 2025 Jan 2;15(1):412. doi: 10.1038/s41598-024-83164-2.
3
Pharmacological Approaches to Hearing Loss.药理学方法治疗听力损失
Pharmacol Rev. 2024 Oct 16;76(6):1063-1088. doi: 10.1124/pharmrev.124.001195.